Tricyclic antidepressant
Dosulepin hydrochloride
Brand names: Prothiaden
Adult dose
Dose: 75mg OD nocte; up to 150mg/day in divided doses
Route: Oral
Frequency: OD–TDS
Clinical pearls
- NICE NG222 depression: NOT recommended for initiation due to high fatality in overdose vs benefit; legacy patients only
- MHRA Drug Safety Update: prescribing only by specialist if other antidepressants unsuitable, lowest effective dose, smallest pack size
- DVLA: warn about driving impairment
Contraindications
- Recent MI
- Heart block / arrhythmias
- Mania
- Severe liver disease
- Concurrent or recent MAOI
- Hypersensitivity
Side effects
- Anticholinergic effects (dry mouth, constipation, urinary retention, blurred vision)
- Sedation
- Postural hypotension
- Cardiac toxicity (QT prolongation, arrhythmia in overdose — high fatality)
- Weight gain
- Sexual dysfunction
Interactions
- MAOIs (serotonin syndrome — washout 14 days)
- SSRIs/SNRIs
- Antipsychotics
- Anticholinergics
- CYP2D6 inhibitors
- QT-prolonging drugs
Monitoring
- Mental state
- Suicidality
- ECG (cardiac risk)
- Weight
- BP
Reference: BNF; NICE NG222; MHRA Drug Safety Update; https://bnf.nice.org.uk/drugs/dosulepin-hydrochloride/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF